NASDAQ:ALNY
Alnylam Pharmaceuticals Stock News
$145.16
-0.160 (-0.110%)
At Close: Apr 18, 2024
Is Alnylam Stock Poised For More Gains After A Stellar 50% Rise In A Month?
06:00am, Tuesday, 23'rd Aug 2022
Alnylam Pharmaceuticals stock (NASDAQ: ALNY), a pharmaceutical company focused on RNA interference therapeutics for genetically defined diseases, has seen a significant rise of 51% in a month.
3 Biopharmas on Buyout Watch
12:00pm, Monday, 22'nd Aug 2022 The Motley Fool
These three biotech companies could be headed for a buyout soon.
3 Biopharmas on Buyout Watch
08:00am, Monday, 22'nd Aug 2022
These three biotech companies could be headed for a buyout soon.
What's Next in Pfizer's M&A Ramp-Up?
12:23pm, Saturday, 20'th Aug 2022 The Motley Fool
Pfizer could be gearing up for a big acquisition.
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that the Company will present data from the APOLLO-B Phase 3 stu
Is This Unknown Growth Stock a Buy After Its Blast Off?
02:23pm, Friday, 12'th Aug 2022 The Motley Fool
It's pursuing a smart and tightly focused drug development strategy that could pay off big.
What Happened This Week: AMTD Revives Meme Action, Alibaba Sparks Speculation
12:20pm, Saturday, 06'th Aug 2022 Investing.com
Where Alnylam Pharmaceuticals Stands With Analysts
02:48pm, Thursday, 04'th Aug 2022 Benzinga
Within the last quarter, Alnylam Pharmaceuticals (NASDAQ:ALNY) has observed the following analyst ratings:
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
2
0
5
0
Intellia Gives Back Alnylam-Inspired Gains As Gene-Editing Safety Questioned
12:39pm, Thursday, 04'th Aug 2022
A gene-editing treatment from Intellia led to elevated liver enzymes in one patient with polyneuropathy, prodding NTLA stock to topple. The post Intellia Gives Back Alnylam-Inspired Gains As Gene-Edit
This Biotechnology Stock Jumped Over 360%; Here Are 106 Biggest Movers From Yesterday
09:54am, Thursday, 04'th Aug 2022 Benzinga
Gainers
Quoin Pharmaceuticals, Ltd. (NASDAQ: QNRX) shares surged 360.5% to settle at $19.80 on Wednesday on above-average volume.
ECMOHO Limited (NASDAQ: MOHO) jumped 146.1% to settle at $0.4085 on a
Moderna, PayPal And Some Other Big Gainers From Wednesday
08:00am, Thursday, 04'th Aug 2022 Benzinga
U.S. stocks closed higher on Wednesday, with the Dow Jones gaining more than 400 points. Here is the list of some big stocks moving higher in the previous session.
Ping Identity Holding Corp. (NYSE:
Why Are Gene Editing Stocks NTLA, ALNY, CRSP, BEAM Up Today?
05:08pm, Wednesday, 03'rd Aug 2022
Gene editing stocks are the talk of Wall Street today as a number of biotech titans enjoy strong gains. It seems a breakthrough clinical trial from Alnylam Pharmaceuticals (NASDAQ: ALNY ) has lifted t
Why Poseida Therapeutics Almost Doubled Today, Here Are 75 Stocks Moving In Wednesday's Mid-Day Session
04:59pm, Wednesday, 03'rd Aug 2022 Benzinga
Gainers
Helius Medical Technologies, Inc. (NASDAQ: HSDT) shares jumped 167% to $1.72 after dropping 13% on Tuesday.
Kaspien Holdings Inc. (NASDAQ: KSPN) gained 112.4% to $5.48.
Eargo, Inc. (NASDAQ: E
Why Alnylam Pharmaceuticals Stock Is Vaulting Higher Today
02:06pm, Wednesday, 03'rd Aug 2022 The Motley Fool
The RNAi drugmaker hits the mark in a rare form of heart failure.
Why Is Alnylam (ALNY) Stock Up 50% Today?
11:33am, Wednesday, 03'rd Aug 2022
Today, Alnylam Pharmaceuticals (NASDAQ: ALNY ) revealed positive top-line results for the company's transthyretin-mediated amyloidosis treatment, patisiran. Alnylam's drug reportedly met its primary
